NEXT Oncology — Irving, Texas

NEXT Oncology is a clinical research site located in Irving, Texas, United States 75039.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

NEXT Oncology has participated in 13 clinical trials with 11 currently active.

Therapeutic areas: Solid Tumor, Cancer, Advanced-stage Solid Tumors.

Sponsors: Boundless Bio, Inc., MBrace Therapeutics, Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology?

NEXT Oncology has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology conducted?

NEXT Oncology has 13 clinical trials on record, with 11 currently active. Their work covers Solid Tumor, Cancer, Advanced-stage Solid Tumors.

Is NEXT Oncology accredited by Crixeo Health?

Yes — NEXT Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NEXT Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.